Articles by Daniel Marsh
Pfizer's Dividend Yield Surges Past 7% as GLP-1 News Weighs on Stock
Pfizer's stock dropped 0.9% to $24.14, boosting its implied dividend yield above 7% after news of a GLP-1 access route in China.
Rezolve AI Soars 12% on $300M Buyback Approval
Rezolve AI (RZLV) jumped 12% after shareholders approved a $300M buyback covering 25.8% of shares, pending UK court sign-off. The plan targets up to 102.7 million shares at current prices.
JCPenney Store Closures Test Mall Landlord Resilience
JCPenney's latest store closures, though a small fraction of its fleet, spotlight the challenges for mall landlords like Simon and Brookfield in managing anchor turnover and redevelopment.
CELZ Surges 252% on S-1 Withdrawal as Traders Eye Dilution
Creative Medical Technology (CELZ) stock surged 252% after withdrawing its S-1 offering, easing dilution fears. Volume soared to 146 million shares.
SoFi Stock Slips on Small-Business Loan Launch Amid Volume Hurdles
SoFi shares fell 1.8% after launching small-business loans, with analysts questioning the volume needed to match Q1 originations.
Plug Power Rises on Russell Index Shift and Asset Sale Deadline
Plug Power shares climbed 4.63% on Tuesday as the Russell index reshuffle placed the stock in growth indexes and the June 30 deadline for a $142 million asset sale arrived.





